Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: British Journal of Cancer, 109, 2, S. 416-421
- Event
-
Veröffentlichung
- (where)
-
Augsburg
- (who)
-
Universität Augsburg
- (when)
-
2013
- Event
-
Veröffentlichung
- (where)
-
Edinburgh
- (who)
-
Nature Publ. Group
- (when)
-
2013
- Creator
-
Stotz, M.
Gerger, A.
Eisner, F.
Szkandera, J.
Loibner, H.
L Ress, A.
Kornprat, P.
A Zoughbi, W.
Seggewies, F. S.
Lackner, C.
Stojakovic, T.
Samonigg, H.
Hoefler, G.
Pichler, Martin
- DOI
-
10.1038/bjc.2013.332
- URN
-
urn:nbn:de:bvb:384-opus4-1052567
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:41 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Stotz, M.
- Gerger, A.
- Eisner, F.
- Szkandera, J.
- Loibner, H.
- L Ress, A.
- Kornprat, P.
- A Zoughbi, W.
- Seggewies, F. S.
- Lackner, C.
- Stojakovic, T.
- Samonigg, H.
- Hoefler, G.
- Pichler, Martin
- Universität Augsburg
- Nature Publ. Group
Time of origin
- 2013
Other Objects (12)
Operationsplanung eloquenter Hirntumoren – vom inoperablen zum operablen Hirntumor
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma : a systematic review and meta-analysis
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Univentricular Patients From Birth to Follow-Up After Fontan—Predicting Lymphatic Abnormalities
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients
A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo
Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage
Operationsplanung eloquenter Hirntumoren – vom inoperablen zum operablen Hirntumor
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma : a systematic review and meta-analysis
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Univentricular Patients From Birth to Follow-Up After Fontan—Predicting Lymphatic Abnormalities
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients
A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo
Neutrophil-to-Lymphocyte Ratio Is an Independent Predictor for In-Hospital Mortality in Spontaneous Intracerebral Hemorrhage
Operationsplanung eloquenter Hirntumoren – vom inoperablen zum operablen Hirntumor
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as prognostic biomarkers in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab
The prognostic value of neutrophil-to-lymphocyte ratio in cholangiocarcinoma : a systematic review and meta-analysis
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratio in Univentricular Patients From Birth to Follow-Up After Fontan—Predicting Lymphatic Abnormalities
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients
A CD99-related antigen on endothelial cells mediates neutrophil but not lymphocyte extravasation in vivo